Masimo Corp

Masimo Corp

MASI

Get informed when a big investor buys or sells

+ Follow
Market Cap$9.34B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Masimo CorpMasimo Corp122.1-10%6.20.7
$180.00

Target Price by Analysts

0.7% upsideMasimo Target Price DetailsTarget Price
$47.41

Current Fair Value

73.5% downside

Overvalued by 73.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.34 Billion
Enterprise Value$9.74 Billion
Dividend Yield$- (-)
Earnings per Share$-2.83
Beta1.13
Outstanding Shares52,200,000

Return

Return on Equity9.67%ROE
Return on Assets4.64%
Return on Invested Capital24.01%

Valuation & Multiples

P/E Ratio122.09P/E Ratio
PEG-91.48PEG
Price to Sales6.16Price to Sales
Price to Book Ratio11.92Price to Book Ratio
Enterprise Value to Revenue6.25
Enterprise Value to EBIT30.8
Enterprise Value to Net Income127
Total Debt to Enterprise0.05
Debt to Equity0.66Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 12, 2026
EPS Estimate
$1.43
Average shareholder expectation
Revenue Estimate
$398.65 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 4, 2026
EPS Estimate
$1.43
Average shareholder expectation
Revenue Estimate
$398.50 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0923 219.81%
Total Calls1,498,735 5410.06%
Total Puts138,400 122.15%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %99.61% 2.90%
Total Invested$9.47B 31.53%
Investors Holding459 62.00%

ESG Score

No data

About Masimo Corp

CEO: Joe Kiani

Relevant Senate Committees

Finance

This powerful committee controls taxation, trade, and entitlement spending (like Medicare). Its decisions on corporate tax policy, tariffs impacting supply chains, and Medicare reimbursement rates for medical devices directly influence Masimo's profitability and market access.

Appropriations

This committee allocates discretionary federal spending. Its subcommittees determine specific funding for federal healthcare programs, scientific research (e.g., NIH), and agencies that purchase medical devices, directly impacting Masimo's potential revenue streams from government contracts.

Health, Education, Labor, and Pensions

This committee has direct oversight over the Food and Drug Administration (FDA), which is the primary regulatory body for electromedical devices. Its decisions on drug and device approvals, as well as labor laws, directly impact Masimo's operations and market access.

Judiciary

This committee oversees antitrust laws and intellectual property (IP). IP protection (patents, trademarks) is critical for medical device companies like Masimo, making this committee's influence on IP law and antitrust enforcement highly relevant for competition and market position.

Veterans' Affairs

This committee oversees the Department of Veterans Affairs (VA). As the VA is a major healthcare provider, its funding and procurement decisions directly impact medical device manufacturers like Masimo, which could supply devices to VA hospitals.